OceanTech Acquisitions I Corp. (NASDAQ:OTEC) announced this morning that it has mutually terminated its combination with drug developer Captura Biopharma.
The parties did not disclose any further details on the termination of the $224 million deal, which was originally announced just two months ago in August, but it is likely that current public market conditions played a role.
In May, OceanTech extended the business combination timeline by six months from June 2 to December 2. The SPAC originally came into the deal with an estimated $106 million in trust and did not supplement this with a PIPE, although it was only required to maintain $5 million in cash available for close.
OceanTech and Captura Biopharma mark the 48th deal to be terminated this year. OceanTech, however, did note in today’s press release that it intends to seek an alternative business combination.
The SPAC initially announced the pricing of its $100 million IPO in May 2021 and intends to combine with a target valued at $250 million to $1 billion in the leisure marine, yachting or super-yachting industries.
A Paradise Acquisition Corp. (NASDAQ:APADU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “APADU”, Wednesday, July 30, 2025. The new SPAC plans to identify a prospective target company in the leisure and entertainment sector that it believes has an optimistic growth...
As the SPAC market reset began last summer, many attributes of what constituted the typical SPAC template began to change. For one, rights came back in a big way. During the previous cycle, SPACs with warrants heavily outnumbered those with rights. Rights tended to be more commonly found in the units of smaller, Asia-based SPACs...
At the SPAC of Dawn Although last week was busy for new S-1 filings and deal announcements, it did mark a slowing of the pace in fresh IPOs. July had been producing a SPAC IPOs at a pace of essentially one per trading day, but that came to an abrupt halt after July 17. It...
Caedryn I (NASDAQ:CAEAU) has filed for a $60 million SPAC hunting for innovation with a repeat sponsor team from China. The new SPAC is offering investors one right to a 1/7 share in each unit and it has not overfunded its trust, but it will be contributing to shareholders if its target search reaches beyond...
At the SPAC of Dawn Healthcare spending represents about 18% of the US economy and the sector has been responsible for about a third of all employment growth in the country recently, but it is also an industry that seems to have fallen off of SPAC radars. Only one SPAC deal has been announced with...